What it is
AMedP-7.6 is the NATO Allied Medical Publication that guides a Combined Joint Force Commander (CJFC) and the medical staff around that commander through the command and planning decisions that medical support to chemical, biological, radiological and nuclear (CBRN) defensive operations requires. It is written at the operational level, for the headquarters that plans and runs an operation, not for the personnel who deliver care at the point of wounding: the guide itself says it "contrasts with AMedP-7.1, which considers medical support in MTFs and at the tactical unit level." Nations record their agreement to use AMedP-7.6 in STANAG 2873. The edition in front of us is Edition A, Version 1, promulgated in February 2018, effective on receipt, and it replaces the earlier AMedP-7, Edition D.
The guide sits beneath NATO's wider medical and CBRN doctrine rather than standing alone. It is subordinate to the overarching joint medical doctrine for CBRN operations, AJMedP-7, and it builds its own planning on the general medical planning process set out in AJMedP-1. It works from the CBRN defence concept in AJP-3.8 and the medical command and control structure defined in the overarching Allied medical support doctrine, AJP-4.10.
Who is responsible for what
The guide is explicit about roles, and about the fact that they are not held by the same person. The Medical Advisor is "the senior medical staff officer in a formation headquarters who is responsible for ensuring that the commander and his staff are properly aware of the health and medical implications of their actions." The Medical Director is "the functional head of the medical services in a formation or theatre of operations," and may also hold the Medical Advisor role for a senior commander. The Medical Coordination Cell (MEDCC) is "the executing body of the medical organization," working under the Medical Director's direction to coordinate multinational, joint and multifunctional medical issues. Above them, commanders "determine medical support requirements for the mission and coordinate medical planning and support" within the Combined Joint Operations Area (CJOA), and are typically granted coordinating authority to redistribute medical assets as the mission requires.
The five areas of CBRN defence with a medical dimension
The guide organises CBRN medical support around five areas that NATO's own CBRN defence concept identifies as having a medical dimension: detection; information management; physical protection; medical countermeasures and casualty care; and hazard management. A further chapter covers the medical logistics that cuts across all five. For each area, the guide names "those medical issues and tasks that require command decisions or direction," leaving the clinical and technical detail behind each to the family of publications it points to, principally AMedP-7.1 for medical management and ATP-3.8.1 for CBRN defence on operations generally.
Detection covers how medical health and disease surveillance contributes to recognising that a CBRN incident has occurred, and the command decisions that follow from it. Information management covers how medical information is collected, protected and shared with the commander and with CBRN defence staff, drawing on the definition of information management in AJP-6. Physical protection covers the operational and medical considerations around the use of protective equipment, a responsibility the guide describes as fundamentally operational and logistical rather than medical. Medical countermeasures and casualty care covers the command decisions around when and how countermeasures are used and how casualties are managed, without prescribing the countermeasures or the clinical content itself. Hazard management covers the containment measures taken to limit the operational impact of an incident, and the command and staff coordination that requires.
Planning across three phases
The guide structures planning around three phases of a CBRN incident: before it happens, during it, and after it. Pre-incident planning is the most detailed of the three, and covers medical and non-medical support and resource considerations a commander's staff should work through as part of the wider operational risk assessment. During an incident, the priority for Medical Advisors and Medical Directors is collecting, assessing and disseminating information to support the force. Post-incident, the guide describes updating courses of action on the basis of the information gathered, and reassessing plans for their continued relevance.
A concrete planning artefact the guide describes is a decision authorities matrix: a document that identifies the types of decisions that may need to be made in response to a CBRN incident, the authorities responsible for making them, and the conditions under which each decision should be made. Producing one, and keeping the roles above filled and understood, is what NATO's own exercise and readiness processes actually check for.
What it does not cover
AMedP-7.6 is explicit about its own limits. It sets no clinical treatment protocols, training standards, casualty-estimation methodology or laboratory requirements: those are the subject of other publications in the family it points to, principally AMedP-7.1 at the tactical level. It does not itself define what equipment, medicines or specific procedures a medical unit uses; it defines who decides, who coordinates, and when.